Loading...
3054 logo

LIWANLI Innovation Co., Ltd.TWSE:3054 Stock Report

Market Cap NT$5.4b
Share Price
NT$67.10
NT$0.12
53.6k% overvalued intrinsic discount
1Y170.6%
7D-4.6%
Portfolio Value
View

LIWANLI Innovation Co., Ltd.

TWSE:3054 Stock Report

Market Cap: NT$5.4b

LIWANLI Innovation (3054) Stock Overview

Operates in the biomedical science industry in Taiwan and internationally. More details

3054 fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance3/6
Financial Health6/6
Dividends0/6

3054 Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

LIWANLI Innovation Co., Ltd. Competitors

Price History & Performance

Summary of share price highs, lows and changes for LIWANLI Innovation
Historical stock prices
Current Share PriceNT$67.10
52 Week HighNT$96.00
52 Week LowNT$22.00
Beta-0.56
1 Month Change-0.45%
3 Month Change114.38%
1 Year Change170.56%
3 Year Change251.31%
5 Year Change221.05%
Change since IPO-68.04%

Recent News & Updates

Recent updates

A Look At LIWANLI Innovation's (TPE:3054) Share Price Returns

Dec 15
A Look At LIWANLI Innovation's (TPE:3054) Share Price Returns

Shareholder Returns

3054TW TechTW Market
7D-4.6%0.6%3.0%
1Y170.6%55.7%97.5%

Return vs Industry: 3054 exceeded the TW Tech industry which returned 55.7% over the past year.

Return vs Market: 3054 exceeded the TW Market which returned 97.5% over the past year.

Price Volatility

Is 3054's price volatile compared to industry and market?
3054 volatility
3054 Average Weekly Movement15.7%
Tech Industry Average Movement6.6%
Market Average Movement5.9%
10% most volatile stocks in TW Market12.1%
10% least volatile stocks in TW Market2.5%

Stable Share Price: 3054's share price has been volatile over the past 3 months compared to the TW market.

Volatility Over Time: 3054's weekly volatility has increased from 8% to 16% over the past year.

About the Company

FoundedEmployeesCEOWebsite
1980n/aJason Chenwww.liwanli.com.tw

LIWANLI Innovation Co., Ltd. operates in the biomedical science industry in Taiwan and internationally. The company offers Vigoway and powder collection products for males, females, the elderly, and children. Its products include black elderberry powder, probiotic enzymes, oral care tablets, resveratrol red grape extract, e-soothing powder, tooth guard tablets, bovine and goat’s milk bites, bilberry tablets, drops, and other products.

LIWANLI Innovation Co., Ltd. Fundamentals Summary

How do LIWANLI Innovation's earnings and revenue compare to its market cap?
3054 fundamental statistics
Market capNT$5.38b
Earnings (TTM)NT$273.23m
Revenue (TTM)NT$243.15m
19.8x
P/E Ratio
22.3x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
3054 income statement (TTM)
RevenueNT$243.15m
Cost of RevenueNT$106.44m
Gross ProfitNT$136.71m
Other Expenses-NT$136.52m
EarningsNT$273.23m

Last Reported Earnings

Mar 31, 2026

Next Earnings Date

n/a

Earnings per share (EPS)3.39
Gross Margin56.22%
Net Profit Margin112.37%
Debt/Equity Ratio0%

How did 3054 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/05/05 14:58
End of Day Share Price 2026/05/05 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

LIWANLI Innovation Co., Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.